1
|
An Inhibitor of Nuclear Factor-Kappa B Pathway Attenuates the Release of TGF-β1 and Inhibits the Fibrogenic Progress in a Model of Airway Remodeling Induced by Acrolein. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE 2022; 2022:4984634. [PMID: 35432586 PMCID: PMC9007674 DOI: 10.1155/2022/4984634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/18/2022] [Revised: 03/18/2022] [Accepted: 03/22/2022] [Indexed: 12/01/2022]
Abstract
Airway inflammation, airway hypersecretion, and airway remodeling are believed to be involved in the process of lung fibrosis. Nowadays, acrolein is widely used to establish the model of airway remodeling. An active component of propolis, named caffeic acid phenethyl ester (CAPE), is recognized as an inhibitor of the NF-κB pathway and shows anti-inflammatory effect. The purpose of this study was to investigate the protective effect of CAPE on acrolein-induced airway remodeling. 24 mice were divided into 4 groups: control group; acrolein group, mice received acrolein (inhalation of acrolein for 20 days); CAPE group, mice received CAPE (30 mg/kg); and acrolein+CAPE group, mice received acrolein and CAPE. After 20 days, lung tissue was removed for histopathology and immunohistochemical evaluations. TGF-β1 and Muc5ac levels were measured at the protein and molecular levels. Additionally, the phospho-P65/P65 values in the airway smooth muscle cells treated with TGF-β1 or CAPE were detected by Western blot. The results showed that compared with the control, subepithelial collagen deposition, airway inflammation, and peribronchus fibrosis were inhibited in the group treated with CAPE. Furthermore, TGF-β1 was significantly decreased in the acrolein+CAPE group compared with the acrolein group. Additionally, we identified CAPE inhibited P65 phosphorylation. However, CAPE did not inhibit the Muc5ac overproduction and hypersecretion induced by acrolein. In conclusion, as an inhibitor of the NF-κB pathway, CAPE attenuated the release of TGF-β1, which inhibited the fibrogenic progress induced by acrolein in mice and took no effect on inhibiting airway mucus hypersecretion.
Collapse
|
3
|
Chen X, Han Y, Zhang B, Liu Y, Wang S, Liao T, Deng Z, Fan Z, Zhang J, He L, Yue W, Li Y, Pei X. Caffeic acid phenethyl ester promotes haematopoietic stem/progenitor cell homing and engraftment. Stem Cell Res Ther 2017; 8:255. [PMID: 29116023 PMCID: PMC5678809 DOI: 10.1186/s13287-017-0708-x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2017] [Revised: 08/24/2017] [Accepted: 10/23/2017] [Indexed: 11/24/2022] Open
Abstract
Background Several studies have suggested that caffeic acid phenethyl ester (CAPE) can induce the expression of hypoxia inducible factor-1α (HIF-1α) protein. We determined whether CAPE has a novel function in improving the homing and engraftment of haematopoietic stem/progenitor cells (HSPCs) by regulating HIF-1α gene expression in the bone marrow (BM) niche. Methods For survival experiments, lethally irradiated C57BL/6 mice were injected with a low number of BM mononuclear cells (MNCs) and CAPE according to the indicated schedule. Homing efficiency analysis was conducted using flow cytometry and colony-forming unit (CFU) assays. The influence of intraperitoneal injection of CAPE on short-term and long-term engraftment of HSPCs was evaluated using competitive and non-competitive mouse transplantation models. To investigate the mechanism by which CAPE enhanced HSPC homing, we performed these experiments including Q-PCR, western blot, immunohistochemistry and CFU assays after in-vivo HIF-1α activity blockade. Results CAPE injection significantly increased the survival rate of recipient mice after lethal irradiation and transplantation of a low number of BM MNCs. Using HSPC homing assays, we found that CAPE notably increased donor HSPC homing to recipient BM. The subsequent short-term and long-term engraftment of transplanted HSPCs was also improved by the optimal schedule of CAPE administration. Mechanistically, we found that CAPE upregulated the expression of HIF-1α, vascular endothelial growth factor-A (VEGF-A) and stromal cell-derived factor 1α (SDF-1α). The HIF-1α inhibitor PX-478 blocked CAPE-enhanced HSPC homing, which supported the idea that HIF-1α is a key target of CAPE. Conclusions Our results showed that CAPE administration facilitated HSPC homing and engraftment, and this effect was primarily dependent on HIF-1α activation and upregulation of SDF-1α and VEGF-A expression in the BM niche. Electronic supplementary material The online version of this article (doi:10.1186/s13287-017-0708-x) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Xiaofang Chen
- School of Laboratory Medicine and Biotechnology, Southern Medical University, No. 1838 Guangzhou Avenue North, Baiyun District, Guangzhou, 510515, China.,Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China.,South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China
| | - Yi Han
- Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China
| | - Bowen Zhang
- Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China.,South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China
| | - Yiming Liu
- Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China
| | - Sihan Wang
- Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China.,South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China
| | - Tuling Liao
- Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China.,South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China
| | - Ziliang Deng
- South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China.,Guangdong Medical University, No. 1 Xincheng Road, Dongguan, 523808, China
| | - Zeng Fan
- Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China.,South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China
| | - Jing Zhang
- Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China.,South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China
| | - Lijuan He
- Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China.,South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China
| | - Wen Yue
- Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China.,South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China
| | - Yanhua Li
- Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China. .,South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China.
| | - Xuetao Pei
- School of Laboratory Medicine and Biotechnology, Southern Medical University, No. 1838 Guangzhou Avenue North, Baiyun District, Guangzhou, 510515, China. .,Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, No. 27 Taiping Road, Haidian District, Beijing, 100850, China. .,South China Institute of Biomedicine, No. 1 Luoxuan 4th Road, Haizhu District, Guangzhou, 510005, China.
| |
Collapse
|
6
|
Murtaza G, Sajjad A, Mehmood Z, Shah SH, Siddiqi AR. Possible molecular targets for therapeutic applications of caffeic acid phenethyl ester in inflammation and cancer. J Food Drug Anal 2015; 23:11-18. [PMID: 28911433 PMCID: PMC9351751 DOI: 10.1016/j.jfda.2014.06.001] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2014] [Revised: 06/19/2014] [Accepted: 06/24/2014] [Indexed: 01/13/2023] Open
Abstract
Of the various derivatives of caffeic acid, caffeic acid phenethyl ester (CAPE) is a hydrophobic, bioactive polyphenolic ester obtained from propolis extract. The objective in writing this review article was to summarize all published studies on therapeutics of CAPE in inflammation and cancer to extract direction for future research. The possible molecular targets for the action of CAPE, include various transcription factors such as nuclear factor-κB, tissue necrosis factor-α, interleukin-6, cyclooxygenase-2, Nrf2, inducible nitric oxide synthase, nuclear factor of activated T cells, hypoxia-inducible factor-1α, and signal transducers and activators of transcription. Based on the valuable data on its therapeutics in inflammation and cancer, clinical studies of CAPE should also be conducted to explore its toxicities, if any.
Collapse
Affiliation(s)
- Ghulam Murtaza
- Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, Pakistan.
| | - Ashif Sajjad
- Institute of Biochemistry, University of Balochistan, Quetta, Pakistan
| | - Zahid Mehmood
- Institute of Biochemistry, University of Balochistan, Quetta, Pakistan
| | - Syed H Shah
- Department of Statistics, University of Balochistan, Quetta, Pakistan
| | - Abdul R Siddiqi
- Department of Biosciences, COMSATS Institute of Information Technology, Islamabad, Pakistan
| |
Collapse
|